Israel China Biotechnology (ICB) Ltd (ICB) — Net Asset Quality Index
Israel China Biotechnology (ICB) Ltd (ICB) has a Net Asset Quality Index of 38.3% as of June 2021. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA6.66 Million minus total liabilities of ILA4.11 Million yields net assets of ILA2.55 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ICB total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Israel China Biotechnology (ICB) Ltd Net Asset Quality Index Over Time (2015–2020)
This chart shows how Israel China Biotechnology (ICB) Ltd's Net Asset Quality Index has evolved across 6 annual periods from 2015 to 2020. As of June 2021, the index stands at 38.3%, representing net assets of ILA2.55 Million against total assets of ILA6.66 Million ILA. For live market cap and overall valuation, see Israel China Biotechnology (ICB) Ltd stock valuation.
Annual Net Asset Quality Index for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below presents the year-by-year Net Asset Quality Index for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Israel China Biotechnology (ICB) Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2020 | 5.6% | ILA470.00K | ILA8.34 Million | ILA7.87 Million | ▼ -10.7 pp |
| 2019 | 16.3% | ILA1.89 Million | ILA11.57 Million | ILA9.68 Million | ▼ -58.7 pp |
| 2018 | 75.1% | ILA7.41 Million | ILA9.88 Million | ILA2.46 Million | ▲ +217.9 pp |
| 2017 | -142.8% | ILA-1.69 Million | ILA1.18 Million | ILA2.87 Million | ▼ -189.8 pp |
| 2016 | 47.0% | ILA1.91 Million | ILA4.06 Million | ILA2.15 Million | ▼ -23.8 pp |
| 2015 | 70.7% | ILA5.78 Million | ILA8.18 Million | ILA2.39 Million | — |